Pasar al contenido principal

GEL HIDROLIPIDICO COMO MATERIAL SUSTITUTIVO DEL MANTO ACIDO EN PATOLOGIAS CUTANEAS

PID2021-124848OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Phenolic fingerprint, bioactivity and nanoformulation of prunus spinosa L. fruit extract for skin delivery

  • De Luca, Maria
  • Tuberoso, Carlo Ignazio Giovanni
  • Pons Pons, Ramon
  • García Ramón, María Teresa
  • Morán, María del Carmen
  • Ferino, Giulio
  • Vassallo, Antonio
  • Martelli, Giuseppe
  • Caddeo, Carla
The nanoformulation of plant extracts in phospholipid vesicles is a promising strategy to exploit the biological properties of natural bioactive substances and overcome drawbacks such as poor aqueous solubility, chemical instability, low skin permeation and retention time, which strongly limit their topical application. In this study, Prunus spinosa berries were used for the preparation of a hydro-ethanolic extract, which showed antioxidant and antibacterial properties owing to the presence of phenolic compounds. Two types of phospholipid vesicles were developed to improve the applicability as topical formulations. Liposomes and Penetration Enhancer-containing Vesicles were characterized for mean diameter, polydispersity, surface charge, shape, lamellarity, and entrapment efficiency. Additionally, their safety was assayed with different cell models, including erythrocytes and representative skin cell lines., This research was partially funded by the Spanish Government (AEI) and European Union (FEDER) (project PID2021-124848OB-I00) and by the Generalitat de Catalunya (2021 SGR 00507)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cholinium-Based Ionic Liquids as Promising Antimicrobial Agents in Pharmaceutical Applications: Surface Activity, Antibacterial Activity and Ecotoxicological Profile

  • García Ramón, María Teresa
  • Bautista, Elena
  • Fuente, Ana de la
  • Pérez, Lourdes
Cholinium-based ionic liquids are compounds increasingly studied in pharmaceutics and biomedicine to enhance bioavailability in drug delivery systems and as bioactive ingredients in pharmaceutical formulations. However, their potential as antimicrobial agents has scarcely been investigated. Herein, we explored the antimicrobial activity of a series of surface-active cholinium-based ionic liquids (Chol-ILs). For this purpose, Chol-ILs with alkyl chains of 10–16 carbon atoms were synthesized and their self-assembly in aqueous medium was investigated. Subsequently, their antimicrobial activity against a panel of clinically relevant bacteria and their ability to eradicate MRSA and P. aeruginosa PAO1 biofilms was evaluated. Finally, we analyzed the ecotoxicological profile of Chol-ILs in terms of susceptibility to aerobic biodegradation and acute aquatic toxicity against D. magna and V. fisheri. Our results reveal that cholinium-based ILs with alkyl chain lengths ≥12 C show a broad spectrum of antibacterial activity. Their antimicrobial efficacy depends on their hydrophobicity, with the C14–C16 homologs being the most effective compounds. These ILs exhibit antimicrobial activity similar to that of imidazolium ILs and quaternary ammonium antiseptics. Moreover, the longer alkyl chain Chol-ILs are able to eradicate established biofilms at concentrations as low as 16–32 µg/mL. The biodegradation rate of cholinium-based ILs decreases with alkyl chain elongation. Our results reinforce the suitability of Chol-ILs as promising multifunctional compounds for application in pharmaceutical and biomedical formulation., This research was partially funded by the Spanish Government (AEI) and European Union (FEDER) (project PID2021-124848OB-I00) and by the Generalitat de Catalunya (2021 SGR 00507)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Tailored design of a water-based nanoreactor technology for producing processable sub-40 Nm 3D COF nanoparticles at atmospheric conditions

  • Llauradó-Capdevila, Gemma
  • Veciana, Andrea
  • Guarducci, Maria Aurora
  • Mayoral, Álvaro
  • Pons Pons, Ramon
  • Hertle, Lukas
  • Ye, Hao
  • Mao, Minmin
  • Sevim, Semih
  • Rodríguez-San-Miguel, David
  • Sorrenti, Alessandro
  • Jang, Bumjin
  • Wang, Zuobin
  • Chen, Xiang-Zhong
  • Nelson, Bradley J.
  • Matheu, Roc
  • Franco, Carlos
  • Pané, Salvador
  • Puigmartí-Luis, Josep
Covalent organic frameworks (COFs) are crystalline materials with intrinsic porosity that offer a wide range of potential applications spanning diverse fields. Yet, the main goal in the COF research area is to achieve the most stable thermodynamic product while simultaneously targeting the desired size and structure crucial for enabling specific functions. While significant progress is made in the synthesis and processing of 2D COFs, the development of processable 3D COF nanocrystals remains challenging. Here, a water-based nanoreactor technology for producing processable sub-40 nm 3D COF nanoparticles at ambient conditions is presented. Significantly, this technology not only improves the processability of the synthesized 3D COF, but also unveils exciting possibilities for their utilization in previously unexplored domains, such as nano/microrobotics and biomedicine, which are limited by larger crystallites., This work was supported by the Swiss National Science Foundation (Project Nos. 200021_181988 and IZLCZ0_206033) and Grant No. PID2020-116612RB-C33 funded by MCIN/ AEI /10.13039/501100011033. J.P.-L. and S.P. also acknowledged support from the European Union's Horizon Europe Research and Innovation Programme under the EVA project (GA No. 101047081) and the Swiss Secretariat for Education, Research and Innovation (SERI), respectively. A.M. acknowledged the MCIN (No. RYC2018-024561-I) and the regional government of Aragon (No. DGA E13_20R). J.P.-L. acknowledges the Agencia Estatal de Investigación (AEI) for the María de Maeztu, Project No. CEX2021-001202-M and the Generalitat de Catalunya (2021 SGR 00270).R.P. acknowledges the Spanish government (AEI) and European Union (FEDER) (project PID2021-1248480B-100) and the Generalitat de Catalunya (2021 SGR 00507). B.J. acknowledged the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. NRF-2022R1C1C1007338). B.J.N. acknowledges the SNSF-Sinergia Project No: 198643. The Scientific Center for Optical and Electron Microscopy (ScopeM), and the FIRST laboratory in ETH Zurich are acknowledged for their technical support. R.M. acknowledged support from the Ramón y Cajal Fellowship (Ref. RYC2021-031578-I) and from “la Caixa” Foundation (ID 100010434) for a Junior Leader fellowship (LCF/BQ/PI22/11910024). Diffraction experiments were performed at XALOC beamline at ALBA Synchrotron Light Facility with the collaboration of ALBA staff. Additionally, the authors acknowledged the use of instrumentation as well as the technical advice provided by the National Facility ELECMI ICTS node “Laboratorio de Microscopías Avanzadas” at the University of Zaragoza, and by Jaume Caelles, from the SAXS - WAXS services at IQAC., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2021-001202-M)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A Nano-Based Approach to Deliver Satureja thymbra Essential Oil to the Skin: Formulation and Characterization

  • Pani, Simone
  • Caddeo, Carla
  • Sanna, Cinzia
  • Pintus, Francesca
  • Floris, Sonia
  • Pons Pons, Ramon
  • Dupont, Aurélien
  • Tuberoso, Carlo Ignazio Giovanni
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/)., Essential oils are well known for their biological properties, making them useful for the treatment of various diseases. However, because of their poor stability and high volatility, their potential cannot be fully exploited. The use of nanoformulations to deliver essential oils can solve these critical issues and amplify their biological activities. We characterized an essential oil from Satureja thymbra via GC–MS and HPLC–DAD to provide qualitative and quantitative data. The essential oil was formulated in phospholipid vesicles which were characterized for size, surface charge, and storage stability. The entrapment efficiency was evaluated as the quantification of the major monoterpenoid phenols via HPLC–DAD. The morphological characterization of the vesicles was carried out via cryo-TEM and SAXS analyses. The essential oil’s antioxidant potential was assayed via two colorimetric tests (DPPH• and FRAP) and its cytocompatibility was evaluated in HaCaT skin cell cultures. The results showed that the nanoformulations developed for the loading of S. thymbra essential oil were below 100 nm in size, predominantly unilamellar, stable in storage, and had high entrapment efficiencies. The vesicles also displayed antioxidant properties and high cytocompatibility. These promising findings pave the way for further investigation of the therapeutic potential of S. thymbra nanoformulations upon skin application., This publication was produced during Simone Pani’s attendance of the Ph.D. programme in Life, Environmental, and Drug Sciences at the University of Cagliari, Cycle XXXVIII, with the support of a scholarship co-financed by the Ministerial Decree no. 352 of 9 April 2022, based on the European Union-funded NextGenerationEU NRRP, Mission 4 “Education and Research”, Component 2 “From Research to Business”, Investment 3.3, and by the company Bioinnova S.r.l.s. (Potenza, Italy). This research was partially funded by the Spanish Government (AEI) and European Union (FEDER) (project PID2021-124848OB-I00) and by the Generalitat de Catalunya (2021 SGR 00507)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Lipid-Based Gels for Delivery of 3-O-Ethyl L-Ascorbic acid in Topical Applications

  • Loza-Rodríguez, Noèlia
  • Millán-Sánchez, Aina
  • Mallandrich, Mireia
  • Calpena, Ana Cristina
  • López, Olga
This study explores the incorporation of 10% 3-O-ethyl L-ascorbic acid (ETVC), a derivative of vitamin C, into two lipid gel systems: a hydrogel (HG) consisting exclusively of lipids and water and a bigel (BG) combining the hydrogel with an oleogel made from olive oil and beeswax. We investigated the ETVC release profiles from both materials using synthetic membranes and measured their permeation through porcine skin in vitro. Additionally, the interaction of these lipid gel systems with the stratum corneum (SC) was determined. Results from the release study indicate that the BG exhibited slower ETVC release compared to the HG. The permeation experiments showed that the presence of lipids in the formulations enhanced ETVC retention in the skin. The HG delivered a higher amount to the SC, while the BG achieved greater retention in the epidermis. This difference is attributed to the different lipophilic nature of each material. The structural analysis of SC lipids revealed that the organization of surface lipids remained unaltered by the application of the gels. Finally, an in vitro efficacy test in porcine skin using methylene blue indicated that our ETVC gels exhibited antioxidant activity. These findings provide valuable insights into the potential of lipidbased gels for topical applications, This work was supported by funds from the Spanish Ministry of Science and Innovation with Ayudas para contratos para la formación de doctores en empresas “Doctorados Industriales”, DIN2019-010777, Bicosome S.L., the Mechanism for the Recovery and Resilience of the European Union and MICINN with the CPP2021-008954 project and PID2021-124848OB-I00 project, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Evaluation of Preclinical Efficacy of Curcumin-Loaded Bicosome Systems in Amelioration of Oral Mucositis

  • Vergara, Daniela
  • Sanhueza, Claudia
  • Méndez, Susana
  • Bustamante, Mariela
  • Vega, Benjamín
  • Acevedo, Francisca
  • López, Olga
[Background/Objectives] Oral mucositis (OM) is a common and debilitating side effect of cancer therapy, characterized by ulceration or inflammation of the oral mucosa. This study evaluates the preclinical efficacy of curcumin-loaded bicosome systems (cur-BS) in mitigating chemotherapy-induced OM in mice., [Methods] BS were prepared using a combination of 1,2-di-palmitoyl-sn-glycero-3-phosphocholine (DPPC) and 1,2-dihexanoyl-sn-glycero-3-phosphocholine (DHPC), α-tocopherol, and curcumin, encapsulated within liposomal vesicles. Three formulations with different curcumin concentrations (180, 540, and 900 μM) were characterized by particle size, polydispersity index (PDI), encapsulation efficiency (EE), appearance, and morphology. The formulation with the highest concentration (cur-BS 5×) was selected for ex vivo permeability studies, release profile analysis, and in vitro anti-inflammatory efficacy. OM was induced in mice using 5-fluorouracil (5-FU) and acetic acid. Cur-BS 5× was compared to the commercial product Dentoxol®. Results: The results showed that cur-BS 5× provided sustained release through a mechanism involving both diffusion and matrix relaxation, enhancing curcumin retention in deeper skin layers. Treatment with cur-BS 5× downregulated the expression of inflammatory markers (IL-1β and TNF-α). Macroscopic assessments demonstrated that both cur-BS 5× and Dentoxol® reduced OM severity, with the greatest improvement observed between days 6 and 9. By day 24, OM scores were 1.25 ± 0.5 for cur-BS 5× and 1.0 ± 0.0 for Dentoxol®, indicating effectiveness in both treatments. However, histological analysis revealed superior tissue recovery with cur-BS 5×, showing better epithelial structure and reduced inflammation. Cur-BS 5×-treated mice also exhibited greater weight recovery and higher survival rates compared to the Dentoxol® group., [Conclusions] These findings suggest that cur-BS 5× may enhance OM treatment, offering outcomes comparable to or better than those of Dentoxol®., This research was funded by the Agencia Nacional de Investigación y Desarrollo (ANID) from the Chilean Government through FONDECYT Postdoctoral Project No. 3210533. The Mechanism for the Recovery and Resilience of the European Union and MICINN with the CPP2021-008954 project, PID2021-124848OB-I00 project, and ANID-Milenio-NCN2023_054 project., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A lipid hydrogel to transport and release an anti-HIV-1 peptide into vaginal mucosa

  • Loza-Rodríguez, Noèlia
  • Millán-Sánchez, Aina
  • Benítez, Aleix
  • Pons Pons, Ramon
  • Gómara Elena, María José
  • Haro Villar, Isabel
  • Genescà, Meritxell
The cervicovaginal mucosa is a main portal of entry for the human immunodeficiency virus (HIV). Peptide antiretroviral therapy is a promising treatment to decrease the HIV infection rate, but yet it presents several weaknesses such as poor bioavailability, development of drug resistance and poor ability to reach the mucosal tissue with the effective concentration. In this work, an HIV inhibitor peptide (RE-E1P47) was encapsulated into a lipidic hydrogel (HG) to test its capacity to deliver the peptide to mucosa ex vivo and its pre-exposure prophylactic efficacy to inhibit or limit HIV infection. The proposed HG is made only with lipids and water and has a composition similar to the vaginal fluid that naturally covers the mucosa. Characterization studies with confocal microscopy, ATR-FTIR, SAXS and WAXS reveal that peptide incorporation does not alter the hydrogel's micro- and nanostructure. Permeation and diffusion tests confirm peptide delivery to the surface layers of the mucosal tissue without interaction or diffusion into a vaginal fluid simulant (VFS). Importantly, efficacy studies demonstrate a significant reduction in HIV infection rates of 60% after HG treatment. Thus, we highlight this material formulation as a strong candidate for mucosal topical application, particularly in the development of pre-exposure prophylaxis (PrEP) treatments against HIV-1., This work was supported by funds from the Spanish Ministry of Science and Innovation with Ayudas para contratos para la formación de doctores en empresas “Doctorados Industriales”, DIN2019-010777, Bicosome S. L., the Mechanism for the Recovery and Resilience of the European Union and MICINN with the CPP2021-008954 project and PID2021-124848OB-I00 project. This work was also supported by grants from the Spanish Health Institute Carlos III (ISCIII, PI20/00160), cofunded by ERDF/ESF, “A way to make Europe”/“Investing in your future”, from MCIN/AEI/10.13039/501100011033 and the European Union “Next Generation EU”/PRTR (CNS2022-135549 and PID2023-149204OB-I00), the Fundació La Marató TV3 (201814-10 FMTV3) and Gilead fellowships (GLD21/00049 and GLD23/00012) to M. G. M. J. G. and I. H. acknowledge the Grant PID2021-122216-OB-I00 received from the Spanish Ministry of Science, Innovation and Universities and the European Regional Development Fund., Peer reviewed